Table 2 Correlation between plasma circN4BP2L2 expression level and clinicopathologic parameters of EOC (N = 126)
From: Plasma circN4BP2L2 is a promising novel diagnostic biomarker for epithelial ovarian cancer
|  | N (%) | CircN4BP2L2, Mean ± SD | P-value |
|---|---|---|---|
Age, years old | |||
  ≤ 50 | 44/126 (35%) | 25.67 ± 13.31 | 0.06 |
  > 50 | 82/126 (65%) | 29.85 ± 27.64 |  |
Histological subtype | |||
 Serous | 73/126 (58%) | 22.33 ± 15.57 | 0.16 |
 Others | 53/126 (42%) | 24.08 ± 24.79 |  |
FIGO stage | |||
 I-II | 36/126 (29%) | 28.57 ± 15.92 | 0.04 * |
 III-IV | 90/126 (71%) | 18.94 ± 25.89 |  |
Tumor grade | |||
 G1 | 46/126 (37%) | 41.81 ± 29.98 | 0.01 * |
 G3 | 80/126 (63%) | 18.93 ± 13.75 |  |
Lymph node metastasis a | |||
 Yes | 50/112 (45%) | 18.27 ± 7.41 | 0.04 * |
 No | 62/112 (55%) | 36.24 ± 27.69 |  |
Distant metastasis | |||
 Yes | 56/126 (44%) | 16.14 ± 8.50 | 0.03 * |
 No | 70/126 (56%) | 34.68 ± 28.91 |  |